相关临床试验
46
20 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
1975
进行中（未招募）
20
43.5%
已完成
23
50.0%
暂停
2
4.3%
终止
1
2.2%
暂无批准数据
- The NIHR Newcastle Commercial Research Delivery Centre recruited the world's first patient to a major commercial study evaluating a novel treatment for chronic obstructive pulmonary disease (COPD). - The first participant was recruited within 103 days, significantly ahead of the UK government's target to reduce commercial trial setup times to under 150 days. - The study is investigating whether a new medicinal product can reduce airway inflammation, improve lung function, and prevent exacerbations by reducing mucus build-up in COPD patients. - This achievement demonstrates the value of the NIHR-ABPI partnership in creating a modern, coordinated research infrastructure that strengthens the UK's competitiveness in life sciences.
- Flatiron Health's international oncology research network has tripled in size over the past year, now encompassing more than 30 partnerships across the UK, Germany, and Japan. - The expansion brings Flatiron's total patient database above 5 million records, with new partnerships including major academic medical centers and national cancer centers in each country. - The company established Flatiron FORUM, a global consortium addressing data transportability challenges to support multinational cancer research and regulatory decisions. - Seven research studies using multinational real-world data have been completed within the past two years, demonstrating the platform's capability for cross-country cohort analyses.
